Nisa Investment Advisors’s Third Harmonic Bio THRD Stock Holding History

Nisa Investment Advisors’s Portfolio THRD Stock Details THRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,423	Closed	–	–	3081
2025 Q3	$0	Hold	3,423	–	–	﹤0.01%	3087
2025 Q2	$18.6K	Buy	3,423 +3,132	+1,076%	+$15.6K	﹤0.01%	1978
2025 Q1	$1.01K	Sell	291 -4,186	-94%	-$20.3K	﹤0.01%	2636
2024 Q4	$46.1K	Buy	4,477 +40	+0.9%	+$498	﹤0.01%	1702
2024 Q3	$60.1K	Sell	4,437 -1,138	-20%	-$14.1K	﹤0.01%	1594
2024 Q2	$72.5K	Buy	5,575 +38	+0.7%	+$470	﹤0.01%	1557
2024 Q1	$52.3K	Hold	5,537	–	–	﹤0.01%	1640
2023 Q4	$60.7K	Buy	5,537 +5,400	+3,942%	+$42.8K	﹤0.01%	1589
2023 Q3	$875	Buy	137 +100	+270%	+$611	﹤0.01%	2415
2023 Q2	$178	Hold	37	–	–	﹤0.01%	2721
2023 Q1	$0	Buy	+37	New	+$157	﹤0.01%	2701

Other funds holding THRD

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Nisa Investment Advisors's THRD Position: Q4 2025 in Review

Nisa Investment Advisors sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 3,423 shares.

Nisa Investment Advisors first reported a position in THRD in Q1 2023 and held it in 11 quarters. The position peaked at $72.5K in Q2 2024. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

Nisa Investment Advisors reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
Nisa Investment Advisors sold 3,423 Third Harmonic Bio shares in Q4 2025.
Nisa Investment Advisors first reported a position in Third Harmonic Bio in Q1 2023 and held it in 11 quarters.
Nisa Investment Advisors's Third Harmonic Bio position peaked at $72.5K in Q2 2024.
4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.